Medico Remedies Limited has informed the Exchange about Bagging/Receiving of orders/contracts

Business Updates View source PDF Explain this filing

MEDICO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.9%Reaction day

₹56.98

prior close

₹56.50

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+2.4%-1.5% vs market

Pharmaceuticals peers, median of 146sector+1.8%-0.9% vs sector

On the reaction day the stock moved 1.5 pts less than Nifty Microcap 250 and 0.9 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.1

15m

+0.1

30m

+1.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.9+2.4-1.5+1.8-0.9

Next day

+0.0+1.1-1.1-0.1+0.1

+4.3+4.6-0.2+2.7+1.6

+2.9+7.9-5.0+5.3-2.3

-1.3+8.8-10.1+5.8-7.1

-0.8+9.6-10.5+6.5-7.3

+3.9+12.2-8.3+7.9-4.0

15d

-5.2+8.6-13.9+6.0-11.2

-8.5+6.2-14.8+3.3-11.8

-11.2+22.7-33.9+10.5-21.7

-27.3+23.5-50.8+10.5-37.8

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 146Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Medico Remedies Limited has informed the stock exchange that it has bagged/received new orders or contracts. No further details such as order value, client name, product type, or contract duration have been disclosed in the headline filing. The announcement falls under routine order-win disclosures required of listed companies on the exchanges. Without the size, customer segment, or geography of these orders, the financial significance cannot be assessed.

Likely market impact

Neutral in the absence of order value or client details. Investors should wait for the full filing or company communication to gauge whether this materially impacts revenue or growth outlook.